ImmunoPrecise Antibodies Ltd (IPA)
0.46
-0.02
(-3.62%)
USD |
NASDAQ |
Nov 14, 16:00
0.50
+0.04
(+8.70%)
After-Hours: 20:00
ImmunoPrecise Antibodies Price to Free Cash Flow
Price to Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Free Cash Flow Data
| Date | Value |
|---|---|
| January 29, 2021 | -- |
| January 28, 2021 | -- |
| January 27, 2021 | -- |
| January 26, 2021 | -- |
| January 25, 2021 | -- |
| January 22, 2021 | -- |
| January 21, 2021 | -- |
| January 20, 2021 | -- |
| January 19, 2021 | -- |
| January 15, 2021 | -- |
| January 14, 2021 | -- |
| January 13, 2021 | -- |
| January 12, 2021 | -- |
| January 11, 2021 | -- |
| January 08, 2021 | -- |
| January 07, 2021 | -- |
| January 06, 2021 | -- |
| January 05, 2021 | -- |
| January 04, 2021 | -- |
| December 31, 2020 | -- |
| December 30, 2020 | -- |
| December 29, 2020 | -- |
| December 28, 2020 | -- |
| December 24, 2020 | -- |
| December 23, 2020 | -- |
| Date | Value |
|---|---|
| December 22, 2020 | -- |
| December 21, 2020 | -- |
| December 18, 2020 | -- |
| December 17, 2020 | -- |
| December 16, 2020 | -- |
| December 15, 2020 | -- |
| December 14, 2020 | -- |
| December 11, 2020 | -- |
| December 10, 2020 | -- |
| December 09, 2020 | -- |
| December 08, 2020 | -- |
| December 07, 2020 | -- |
| December 04, 2020 | -- |
| December 03, 2020 | -- |
| December 02, 2020 | -- |
| December 01, 2020 | -- |
| November 30, 2020 | -- |
| November 27, 2020 | -- |
| November 25, 2020 | -- |
| November 24, 2020 | -- |
| November 23, 2020 | -- |
| November 20, 2020 | -- |
| November 19, 2020 | -- |
| November 18, 2020 | -- |
| November 17, 2020 | -- |
Price to Cash Flow Definition
Price to free cash flow measures the Price / TTM Free Cash Flow. Like other price ratios (ie. PE Ratio, PS Ratio, P/B Ratio), this metric can be used to compare companies with similar capital structures. Free cash flow gives an idea of how much cash is available for shareholders through stock buybacks and dividend payouts. A lower price to free cash flow is more desirable when assessing different companies.